Marinus Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
If you work at Marinus Pharmaceuticals Inc and you wish to licence your ESG aseessment, please contact us. The report of Marinus Pharmaceuticals Inc employs information from across the web and also from public documents by Marinus Pharmaceuticals Inc. Alternative corporations in the rating peer group for Marinus Pharmaceuticals Inc are shown below.
Marinus Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 6.4, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 315 | Pluristem Therapeutics Inc | 7.2 | High |
| 315 | Regeneron Pharmaceuticals Inc | 7.2 | High |
| 326 | Marinus Pharmaceuticals Inc | 7.1 | High |
| 326 | BOD Australia Ltd | 7.1 | High |
| 326 | Abionyx Pharma SA | 7.1 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Marinus Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Marinus Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Marinus Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Marinus Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Marinus Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Marinus Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Marinus Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.